ANIX: Anixa Biosciences, Inc. Stock

by  •  • Comments Off on ANIX: Anixa Biosciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 94.74
Enterprise Value ($M) 92.74
Book Value ($M) 23.60
Book Value / Share 0.74
Price / Book 4.01
NCAV ($M) 23.45
NCAV / Share 0.74
Price / NCAV 4.04

Profitability (mra)
Return on Invested Capital (ROIC) -0.45
Return on Assets (ROA) -0.39
Return on Equity (ROE) -0.41

Liquidity (mrq)
Quick Ratio 15.19
Current Ratio 15.19

Balance Sheet (mrq) ($M)
Current Assets 25.22
Assets 25.37
Liabilities 1.77
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.21
Operating Income -11.01
Net Income -9.81
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -6.21
Cash from Investing -5.60
Cash from Financing 0.37

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
3 days ago 13D Catelani Michael 5.25
01-16 13D/A Kumar Amit 13.50 42.70

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-01-16 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-09-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-06-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 20,630 114,707 17.98
2024-05-02 6,119 15,250 40.12
2024-05-01 21,904 7,293 300.34
2024-04-30 22,116 20,076 110.16

(click for more detail)

Similar Companies
ALRN – Aileron Therapeutics, Inc. ALZN – Alzamend Neuro, Inc.
ANEB – Anebulo Pharmaceuticals, Inc. APM – Aptorum Group Limited
APRE – Aprea Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io